Medications for weight loss in polycystic ovary syndrome
Pro Research Analysisby 
Searched over 200M research papers
Weight Loss Medications in Polycystic Ovary Syndrome (PCOS): Key Options
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) for Weight Loss in PCOS
GLP-1 receptor agonists, such as liraglutide, are among the most studied medications for weight loss in women with PCOS. These drugs have shown significant reductions in body weight, body mass index (BMI), and abdominal fat in overweight and obese women with PCOS. They also improve metabolic and hormonal parameters, including free testosterone and sex hormone-binding globulin levels, and may increase menstrual frequency and improve reproductive outcomes. The combination of liraglutide with metformin appears to enhance these benefits, leading to greater weight loss and better metabolic control than either drug alone. However, most studies have small sample sizes and short durations, so more research is needed to confirm long-term safety and effectiveness 145.
Metformin and Other Insulin Sensitizers
Metformin is a well-established treatment for PCOS, especially in women with high metabolic risk (BMI >25 kg/m²). It helps reduce excess body weight and improves hormonal and metabolic outcomes, though its effect on weight loss is generally modest compared to newer agents. Inositol, another insulin sensitizer, has limited benefits for weight loss but is associated with fewer side effects than metformin 810.
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Other Novel Agents
Emerging evidence suggests that SGLT2 inhibitors and phosphodiesterase-4 inhibitors may also help with weight loss in women with PCOS, though data are still limited. These medications, originally developed for type 2 diabetes, have shown benefits in reducing body weight and improving insulin resistance, which are key concerns in PCOS management 239.
Anti-Obesity Medications and Bariatric Surgery
When lifestyle changes and first-line medications are insufficient, anti-obesity drugs can be considered as part of a comprehensive approach to weight management in PCOS. For women with severe obesity who do not respond to other treatments, bariatric surgery is an option and has been shown to improve health and fertility outcomes 789.
Conclusion
GLP-1 receptor agonists, especially liraglutide, are currently the most promising medications for weight loss in women with PCOS, often providing additional metabolic and hormonal benefits. Metformin remains a useful option, particularly for those with high metabolic risk, while SGLT2 inhibitors and other novel agents are emerging as potential therapies. Anti-obesity medications and bariatric surgery may be considered for those with more severe obesity. More large-scale, long-term studies are needed to determine the best medication strategies for weight loss in PCOS and to ensure their safety and effectiveness over time 1234+4 MORE.
Sources and full results
Most relevant research papers on this topic